Chitosan thiolate NPs loaded with intranasally administered GAL were superior biochemically and pharmacokinetically, and inhibited AChE activity in the brain of Swiss albino mice compared to conventional oral administration of this drug in AD therapy [180]. Here, ACHE is linked to Alzheimer disease.